Results
|
|
121.
|
|
|
|
122.
|
|
|
|
123.
|
|
|
|
124.
|
|
|
|
125.
|
|
|
|
126.
|
Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors. [electronic resource] by
- Molife, L Rhoda
- Rudman, Sarah M
- Alam, Salma
- Tan, Daniel S-W
- Kristeleit, Hartmut
- Middleton, Gary
- Propper, David
- Bent, Liz
- Stopfer, Peter
- Uttenreuther-Fischer, Martina
- Wallenstein, Gudrun
- de Bono, Johann
- Spicer, James
Producer: 20140130
In:
Cancer chemotherapy and pharmacology vol. 72
Availability: No items available.
|
|
|
127.
|
|
|
|
128.
|
|
|
|
129.
|
Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumors. [electronic resource] by
- Yap, Timothy A
- Vidal, Laura
- Adam, Jan
- Stephens, Peter
- Spicer, James
- Shaw, Heather
- Ang, Jooern
- Temple, Graham
- Bell, Susan
- Shahidi, Mehdi
- Uttenreuther-Fischer, Martina
- Stopfer, Peter
- Futreal, Andrew
- Calvert, Hilary
- de Bono, Johann S
- Plummer, Ruth
Producer: 20101006
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28
Availability: No items available.
|
|
|
130.
|
|
|
|
131.
|
|
|
|
132.
|
Complete Response to Immunotherapy Plus Chemotherapy After an Unusual Clinical Response to Afatinib and Stereotactic Radiosurgery in a Patient With Metastatic EGFR-Mutant Non-Small-Cell Lung Cancer. [electronic resource] by
- Pizarro, Gonzalo
- Pinto, Mauricio P
- Muñoz-Medel, Matías
- Cordova-Delgado, Miguel
- Bravo, M Loreto
- Nervi, Bruno
- Sánchez, César
- Ibañez, Carolina
- Peña, José
- Walbaum, Benjamín
- Madrid, Jorge
- Briones, Juan
- Koch, Erica
- Valbuena, Jose
- Gonzalez, Sergio
- Gejman, Roger
- Acevedo, Francisco
- Mondaca, Sebastian
- Garrido, Marcelo
- Vines, Eugenio
- Galindo, Hector
Producer: 20210705
In:
Clinical lung cancer vol. 21
Availability: No items available.
|
|
|
133.
|
Phase II study of Afatinib as third-line treatment for patients in Korea with stage IIIB/IV non-small cell lung cancer harboring wild-type EGFR. [electronic resource] by
- Ahn, Myung-Ju
- Kim, Sang-We
- Cho, Byoung-Chul
- Ahn, Jin Seok
- Lee, Dae Ho
- Sun, Jong-Mu
- Massey, Dan
- Kim, Miyoung
- Shi, Yang
- Park, Keunchil
Producer: 20150419
In:
The oncologist vol. 19
Availability: No items available.
|
|
|
134.
|
Small Cell Lung Cancer Derived from Adenocarcinoma with Mutant Epidermal Growth Factor Receptor Provides a Signature of Transcriptional Alteration in Tumor Cells. [electronic resource] by
- Tenjin, Yuki
- Nakamura, Kazuyoshi
- Ishizuka, Shiho
- Saruwatari, Koichi
- Sato, Ryo
- Tomita, Yusuke
- Saeki, Sho
- Ichiyasu, Hidenori
- Fujii, Kazuhiko
- Ito, Takaaki
- Sakagami, Takuro
Producer: 20200210
In:
Internal medicine (Tokyo, Japan) vol. 58
Availability: No items available.
|
|
|
135.
|
|
|
|
136.
|
|
|
|
137.
|
|
|
|
138.
|
|
|
|
139.
|
|
|
|
140.
|
|